View ValuationFabtech Technologies 将来の成長Future 基準チェック /06現在、 Fabtech Technologiesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Life Sciences 収益成長26.3%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • May 05New minor risk - Dividend sustainabilityThe company has a short dividend paying track record. Less than a year of continuous dividend payments. Dividend yield: 0.4% This is considered a minor risk. For dividend focussed investors, companies that have not established a long-term track record of consistently maintaining or growing dividends are less attractive than those companies that have a long track record. Those that have a long track record have proven their underlying business is stable enough to consistently maintain or grow the dividend and that the company considers maintaining the dividend to be one of its priorities. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Short dividend paying track record (less than a year of continuous dividend payments). Share price has been volatile over the past 3 months (9.1% average weekly change). Profit margins are more than 30% lower than last year (8.9% net profit margin). Market cap is less than US$100m (₹7.37b market cap, or US$77.3m).分析記事 • May 05Fabtech Technologies' (NSE:FABTECH) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsDespite Fabtech Technologies Limited's ( NSE:FABTECH ) recent earnings report having lackluster headline numbers, the...Board Change • May 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director Chirag Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Apr 29Full year 2026 earnings released: EPS: ₹10.00 (vs ₹14.34 in FY 2025)Full year 2026 results: EPS: ₹10.00 (down from ₹14.34 in FY 2025). Revenue: ₹4.31b (up 32% from FY 2025). Net income: ₹383.6m (down 17% from FY 2025). Profit margin: 8.9% (down from 14% in FY 2025). The decrease in margin was driven by higher expenses.お知らせ • Apr 22Fabtech Technologies Limited to Report Q4, 2026 Results on Apr 27, 2026Fabtech Technologies Limited announced that they will report Q4, 2026 results at 12:08 PM, Indian Standard Time on Apr 27, 2026New Risk • Mar 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Profit margins are more than 30% lower than last year (8.1% net profit margin). Market cap is less than US$100m (₹6.99b market cap, or US$76.1m).Reported Earnings • Feb 03Third quarter 2026 earnings releasedThird quarter 2026 results: ₹1.56 loss per share. Net loss: ₹56.8m (flat on 3Q 2025).New Risk • Feb 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.0% Last year net profit margin: 14% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (8.0% net profit margin). Market cap is less than US$100m (₹7.25b market cap, or US$80.2m).お知らせ • Jan 29Fabtech Technologies Limited to Report Q3, 2026 Results on Feb 02, 2026Fabtech Technologies Limited announced that they will report Q3, 2026 results on Feb 02, 2026Valuation Update With 7 Day Price Move • Jan 23Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹161, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 30x in the Life Sciences industry in India.New Risk • Dec 26New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.99b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (66% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (₹8.99b market cap, or US$99.9m).Reported Earnings • Oct 29Second quarter 2026 earnings releasedSecond quarter 2026 results: EPS: ₹8.68. Net income: ₹281.1m (up ₹281.1m from 2Q 2025).Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹228, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 45x in the Healthcare industry in India.お知らせ • Oct 17+ 1 more updateFabtech Technologies Limited to Report Q1, 2026 Results on Oct 23, 2025Fabtech Technologies Limited announced that they will report Q1, 2026 results on Oct 23, 2025Board Change • Oct 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Additional Non-Executive Director Chirag Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Fabtech Technologies は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測NSEI:FABTECH - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20264,108384-425N/A12/31/20253,871314N/AN/AN/A9/30/20254,287575-335-87N/A6/30/20253,659345N/AN/AN/A3/31/20253,267465-609-361N/A3/31/20242,261272598610N/A3/31/20231,938217-142-139N/A3/31/20222,572243-84-64N/A3/31/20211,21076-89-88N/A3/31/20201,334117266271N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: FABTECHの予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: FABTECHの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: FABTECHの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: FABTECHの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: FABTECHの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: FABTECHの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 05:31終値2026/05/07 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Fabtech Technologies Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • May 05New minor risk - Dividend sustainabilityThe company has a short dividend paying track record. Less than a year of continuous dividend payments. Dividend yield: 0.4% This is considered a minor risk. For dividend focussed investors, companies that have not established a long-term track record of consistently maintaining or growing dividends are less attractive than those companies that have a long track record. Those that have a long track record have proven their underlying business is stable enough to consistently maintain or grow the dividend and that the company considers maintaining the dividend to be one of its priorities. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Short dividend paying track record (less than a year of continuous dividend payments). Share price has been volatile over the past 3 months (9.1% average weekly change). Profit margins are more than 30% lower than last year (8.9% net profit margin). Market cap is less than US$100m (₹7.37b market cap, or US$77.3m).
分析記事 • May 05Fabtech Technologies' (NSE:FABTECH) Sluggish Earnings Might Be Just The Beginning Of Its ProblemsDespite Fabtech Technologies Limited's ( NSE:FABTECH ) recent earnings report having lackluster headline numbers, the...
Board Change • May 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director Chirag Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Apr 29Full year 2026 earnings released: EPS: ₹10.00 (vs ₹14.34 in FY 2025)Full year 2026 results: EPS: ₹10.00 (down from ₹14.34 in FY 2025). Revenue: ₹4.31b (up 32% from FY 2025). Net income: ₹383.6m (down 17% from FY 2025). Profit margin: 8.9% (down from 14% in FY 2025). The decrease in margin was driven by higher expenses.
お知らせ • Apr 22Fabtech Technologies Limited to Report Q4, 2026 Results on Apr 27, 2026Fabtech Technologies Limited announced that they will report Q4, 2026 results at 12:08 PM, Indian Standard Time on Apr 27, 2026
New Risk • Mar 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Profit margins are more than 30% lower than last year (8.1% net profit margin). Market cap is less than US$100m (₹6.99b market cap, or US$76.1m).
Reported Earnings • Feb 03Third quarter 2026 earnings releasedThird quarter 2026 results: ₹1.56 loss per share. Net loss: ₹56.8m (flat on 3Q 2025).
New Risk • Feb 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 8.0% Last year net profit margin: 14% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (8.0% net profit margin). Market cap is less than US$100m (₹7.25b market cap, or US$80.2m).
お知らせ • Jan 29Fabtech Technologies Limited to Report Q3, 2026 Results on Feb 02, 2026Fabtech Technologies Limited announced that they will report Q3, 2026 results on Feb 02, 2026
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹161, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 30x in the Life Sciences industry in India.
New Risk • Dec 26New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.99b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (66% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (₹8.99b market cap, or US$99.9m).
Reported Earnings • Oct 29Second quarter 2026 earnings releasedSecond quarter 2026 results: EPS: ₹8.68. Net income: ₹281.1m (up ₹281.1m from 2Q 2025).
Valuation Update With 7 Day Price Move • Oct 27Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹228, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 45x in the Healthcare industry in India.
お知らせ • Oct 17+ 1 more updateFabtech Technologies Limited to Report Q1, 2026 Results on Oct 23, 2025Fabtech Technologies Limited announced that they will report Q1, 2026 results on Oct 23, 2025
Board Change • Oct 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Additional Non-Executive Director Chirag Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.